These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Designing and Expression of Recombinant Chimeric Protein Containing CtxB and OmpW from Vibrio Cholerae and Evaluation of Its Immunogenicity. Vakili A; Mousavi Gargari SL; Nazarian S; Amani J Iran J Immunol; 2018 Sep; 15(3):207-220. PubMed ID: 30246696 [TBL] [Abstract][Full Text] [Related]
4. Fusion-expressed CtxB-TcpA-C-CPE improves both systemic and mucosal humoral and T-cell responses against cholera in mice. Souod N; Kargar M; Hoseini MH; Jafarinia M Microb Pathog; 2021 Aug; 157():104978. PubMed ID: 34022352 [TBL] [Abstract][Full Text] [Related]
5. Protective effects of egg yolk immunoglobulins (IgYs) developed against recombinant immunogens CtxB, OmpW and TcpA on infant mice infected with Vibrio cholerae. Taheri F; Nazarian S; Ahmadi TS; Gargari SLM Int Immunopharmacol; 2020 Dec; 89(Pt B):107054. PubMed ID: 33065385 [TBL] [Abstract][Full Text] [Related]
6. The roles of mesoporous silica and carbon nanoparticles in antigen stability and intensity of immune response against recombinant subunit B of cholera toxin in a rabbit animal model. Karimi Bavandpour A; Bakhshi B; Najar-Peerayeh S Int J Pharm; 2020 Jan; 573():118868. PubMed ID: 31765785 [TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge. Kundu J; Mazumder R; Srivastava R; Srivastava BS FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752 [TBL] [Abstract][Full Text] [Related]
9. Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model. Anvari S; Najar-Peerayeh S; Behmanesh M; Bakhshi B Hum Vaccin Immunother; 2018; 14(9):2323-2328. PubMed ID: 29852089 [TBL] [Abstract][Full Text] [Related]
10. Immunogenic efficacy of DNA and protein-based vaccine from a chimeric gene consisting OmpW, TcpA and CtxB, of Vibrio cholerae. Zareitaher T; Sadat Ahmadi T; Latif Mousavi Gargari S Immunobiology; 2022 Mar; 227(2):152190. PubMed ID: 35220071 [TBL] [Abstract][Full Text] [Related]
12. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens. Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059 [TBL] [Abstract][Full Text] [Related]
13. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform. Liao J; Gibson JA; Pickering BS; Watnick PI mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae. John M; Crean TI; Calderwood SB; Ryan ET Infect Immun; 2000 Mar; 68(3):1171-5. PubMed ID: 10678922 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601 [TBL] [Abstract][Full Text] [Related]
16. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108. Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467 [TBL] [Abstract][Full Text] [Related]
17. Investigation into immunological responses against a native recombinant CTB whole-cell Vibrio cholerae vaccine in a rabbit model. Boustanshenas M; Bakhshi B; Ghorbani M J Appl Microbiol; 2013 Feb; 114(2):509-15. PubMed ID: 23082752 [TBL] [Abstract][Full Text] [Related]
18. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera. Ryan ET; Bridges EA; Crean TI; Gausia K; Hamadani JD; Aziz A; Hawkes S; Begum M; Bogaerts J; Faruque SM; Salam MA; Fuchs GJ; Calderwood SB J Infect Dis; 2001 Sep; 184(5):643-7. PubMed ID: 11494170 [TBL] [Abstract][Full Text] [Related]
19. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations. Fernandez-Miyakawa ME; Brero ML; Mateo NA Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of humoral and cellular immune responses against Vibrio cholerae using oral immunization by multi-epitope-phage-based vaccine. Ghafouri E; Fadaie M; Amirkhani Z; Esmaeilifallah M; Rahimmanesh I; Hosseini N; Hejazi H; Khanahmad H Int Immunopharmacol; 2024 Jun; 134():112160. PubMed ID: 38710117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]